臨床的に重要なサンプルから分離された嫌気性細菌に対するエラバシクロリンのインビトロ活性

Cobo et al. (Sun,) はこの問題を研究した。

www.synapsesocial.com/papers/69a76728badf0bb9e87dfd74 — DOI: https://doi.org/10.1016/j.eimc.2026.503103

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides species· 2018 · 32 citations
2. Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria· 2022 · 19 citations
3. The value of MALDI-TOF MS for the identification of clinically relevant anaerobic bacteria in routine laboratories· 2012 · 138 citations
4. Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent· 2011 · 125 citations
5. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies· 2012 · 8,936 citations